Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of patients with stage 3 cutaneous melanoma, according to the results of a single-arm phase 2 clinical trial led by the University of Pittsburgh, UPMC Hillman Cancer Center and the National Cancer Institute (NCI).
Siemens Healthineers launches anatomy hologram app on Apple Vision Pro
Dive Brief: Siemens Healthineers has launched an Apple Vision Pro app to enable people to view interactive holograms of the human body, the medtech company
March 8, 2024